Amgen Total Asset vs. Beta
| AMGN Stock | USD 265.51 1.77 0.66% |
Amgen Total Assets |
|
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.65 | 0.7002 |
|
| |||||
| Net Profit Margin | 0.18 | 0.2383 |
|
| |||||
| Pretax Profit Margin | 0.25 | 0.2786 |
|
| |||||
| Return On Assets | 0.12 | 0.0691 |
|
| |||||
| Return On Equity | 1.13 | 1.0778 |
|
|
For Amgen profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Amgen to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Amgen Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Amgen's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Amgen Inc over time as well as its relative position and ranking within its peers.
Amgen |
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.52) | Dividend Share 8.52 | Earnings Share 12.48 | Revenue Per Share 52.692 | Quarterly Revenue Growth 0.198 |
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Amgen Inc Beta vs. Total Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Amgen's current stock value. Our valuation model uses many indicators to compare Amgen value to that of its competitors to determine the firm's financial worth. Amgen Inc is rated fifth in total asset category among related companies. It is number one stock in beta category among related companies . The ratio of Total Asset to Beta for Amgen Inc is about 163,284,033,613 . At this time, Amgen's Total Assets are very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Amgen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amgen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amgen's earnings, one of the primary drivers of an investment's value.Amgen Beta vs. Total Asset
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Amgen |
| = | 97.15 B |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Amgen |
| = | 0.6 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Amgen Beta Comparison
Amgen is currently under evaluation in beta category among related companies.
Beta Analysis
As returns on the market increase, Amgen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Amgen is expected to be smaller as well.
Amgen Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Amgen, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Amgen will eventually generate negative long term returns. The profitability progress is the general direction of Amgen's change in net profit over the period of time. It can combine multiple indicators of Amgen, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -289 M | -274.6 M | |
| Operating Income | 7.9 B | 4.1 B | |
| Income Before Tax | 7.9 B | 4 B | |
| Total Other Income Expense Net | -42 M | -44.1 M | |
| Net Income | 6.7 B | 3.4 B | |
| Income Tax Expense | 1.1 B | 830.4 M | |
| Net Income Applicable To Common Shares | 7.5 B | 5 B | |
| Net Income From Continuing Ops | 7.6 B | 6.4 B | |
| Non Operating Income Net Other | -732.6 M | -696 M | |
| Interest Income | 230.4 M | 218.9 M | |
| Net Interest Income | -2.5 B | -2.3 B | |
| Change To Netincome | 557.8 M | 379.4 M | |
| Net Income Per Share | 12.56 | 13.18 | |
| Income Quality | 1.26 | 1.13 | |
| Net Income Per E B T | 0.86 | 0.64 |
Amgen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Amgen. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Amgen position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Amgen's important profitability drivers and their relationship over time.
Use Amgen in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.Amgen Pair Trading
Amgen Inc Pair Trading Analysis
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Amgen position
In addition to having Amgen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials ETFs Thematic Idea Now
Financials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
To fully project Amgen's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Amgen Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Amgen's income statement, its balance sheet, and the statement of cash flows.